Anticoagulation in the Cardiovascular Patient - Heart Course Symposium 2017

Las Vegas, NV US
November 8, 2017

The goal of this activity is to evaluate the clinical trial data
on the use of DOACs, the reversal agents, and educate
practitioners on the safe and effective use of these therapies
in an emergency setting.

Target Audience

Physicians, PAs, NPs, RNs

Learning Objectives

1. Review the latest data on the use of anticoagulant therapy and the risks of major bleeding secondary to DOAC use in patients with cardiovascular disease

2. Evaluate the emerging clinical trial data on the use of reversal agents for DOACs in an emergency
3. Discuss the rapid, safe reversal of DOAC therapy in cardiovascular patients presenting to the Emergency Department
 

Course summary
Available credit: 
  • 0.00 ACEP
  • 1.00 AMA PRA Category 1 Credits™
  • 0.00 AOA Category 2A
  • 1.00 Certificate of Participation
Course opens: 
05/01/2017
Course expires: 
11/06/2019
Event starts: 
11/08/2017 - 12:00pm
Event ends: 
11/08/2017 - 7:30pm
Cost:
$0.00
Rating: 
0
Mandarin Oriental Hotel
752 Las Vegas Boulevard South
Las Vegas, NV 89158
United States

Amer Z. Aldeen, MD, FACEP

Laura J. Bontempo, MD, MEd, FACEP, FAAEM

Available Credit

  • 0.00 ACEP
  • 1.00 AMA PRA Category 1 Credits™
  • 0.00 AOA Category 2A
  • 1.00 Certificate of Participation

Accreditation Period

Course opens: 
05/01/2017
Course expires: 
11/06/2019

Price

Cost:
$0.00
Please login or register to take this course.